肺动静脉畸形一例_Chinese Journal of Respiratory and Critical Care Medicine

Authors：

唐晋 ¹ ,  肖军 ²

1. ;
2. ;

Corresponding author：

肖军, Email: xiaojun5244@163.com

Keywords：

DOI：

10.7507/1671-6205.201902037

Video：

Export PDF Favorites Scan Get Citation

Abstract Full text Figures/Tables Video References Cited by

Citation： 唐晋, 肖军. 肺动静脉畸形一例. Chinese Journal of Respiratory and Critical Care Medicine, 2020, 19(5): 505-506. doi: 10.7507/1671-6205.201902037 Copy

1.	Nakayama M, Nawa T, Chonan T, et al. Prevalence of pulmonary arteriovenous malformations as estimated by low-dose thoracic CT screening. Intern Med, 2012, 51(13): 1677-1681.
2.	Faughnan ME, Palda VA, Garcia-Tsao G, et al. HHT Foundation International - Guidelines Working Group. International guidelines for the diagnosis and management of hereditary haemorrhagic telangiectasia. J Med Genet, 2011, 48: 73-87.
3.	Shovlin CL, Guttmacher E, Buscarini E, et al. Diagnostic criteria for hereditary hemorrhagic telangiectasia (Rendu-Osler-Weber syndrome). Am J Med Genet, 2000, 91: 66-67.
4.	Hsu CC, Kwan GN, Thompson SA. Embolisation for pulmonary arteriovenous malformation. Cochrane Database Syst Rev, 2012, 8: CD008017.
5.	Howard LS, Santhirapala V, Murphy K, et al. Cardiopulmonary exercise testing demonstrates maintenance of exercise capacity in patients with hypoxemia and pulmonary arteriovenous malformations. Chest, 2014, 146: 709-718.
6.	Finnamore H, Le Couteur J, Hickson M, et al. Hemorrhage-adjusted iron requirements, hematinics and hepcidin define hereditary hemorrhagic telangiectasia as a model of hemorrhagic iron deficiency. PLoS ONE, 2013, 8: e76516.
7.	Shovlin CL. Pulmonary arteriovenous malformations. Am J Respir Crit Care Med, 2014, 190: 1217-1228.

1. Nakayama M, Nawa T, Chonan T, et al. Prevalence of pulmonary arteriovenous malformations as estimated by low-dose thoracic CT screening. Intern Med, 2012, 51(13): 1677-1681.
2. Faughnan ME, Palda VA, Garcia-Tsao G, et al. HHT Foundation International - Guidelines Working Group. International guidelines for the diagnosis and management of hereditary haemorrhagic telangiectasia. J Med Genet, 2011, 48: 73-87.
3. Shovlin CL, Guttmacher E, Buscarini E, et al. Diagnostic criteria for hereditary hemorrhagic telangiectasia (Rendu-Osler-Weber syndrome). Am J Med Genet, 2000, 91: 66-67.
4. Hsu CC, Kwan GN, Thompson SA. Embolisation for pulmonary arteriovenous malformation. Cochrane Database Syst Rev, 2012, 8: CD008017.
5. Howard LS, Santhirapala V, Murphy K, et al. Cardiopulmonary exercise testing demonstrates maintenance of exercise capacity in patients with hypoxemia and pulmonary arteriovenous malformations. Chest, 2014, 146: 709-718.
6. Finnamore H, Le Couteur J, Hickson M, et al. Hemorrhage-adjusted iron requirements, hematinics and hepcidin define hereditary hemorrhagic telangiectasia as a model of hemorrhagic iron deficiency. PLoS ONE, 2013, 8: e76516.
7. Shovlin CL. Pulmonary arteriovenous malformations. Am J Respir Crit Care Med, 2014, 190: 1217-1228.

Previous Article
以乳糜胸作为首发表现的原发性系统性淀粉样变性一例并文献复习
Next Article
二代基因测序技术确诊嗜肺军团菌肺炎一例

Chinese Journal of Respiratory and Critical Care Medicine

肺动静脉畸形一例

Abstract Full text Figures/Tables Video References Cited by

Previous Article

Next Article

Format

Content